Enveric Biosciences, Inc. (ENVB)

1.39 -0.05 (-3.47%) USD  |  NASDAQ  |  Sep 04, 16:00
1.39 0.00 (0.00%) After-Hours: 20:00
More

Enveric Biosciences SG&A Expense (TTM) : 6.099M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ENVB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 6.099M
March 31, 2026 5.682M
December 31, 2025 5.793M
September 30, 2025 5.997M
June 30, 2025 5.801M
March 31, 2025 5.880M
December 31, 2024 6.454M
September 30, 2024 5.398M
June 30, 2024 6.172M
March 31, 2024 8.030M
December 31, 2023 8.881M
September 30, 2023 10.77M
June 30, 2023 12.28M
March 31, 2023 11.62M
December 31, 2022 11.61M
September 30, 2022 18.42M
June 30, 2022 17.03M
March 31, 2022 16.84M
December 31, 2021 20.67M
September 30, 2021 11.47M
June 30, 2021 10.06M
March 31, 2021 8.587M
September 30, 2020 5.114M
June 30, 2020 7.590M
March 31, 2020 10.17M
Date Value
December 31, 2019 12.21M
September 30, 2019 11.81M
June 30, 2019 11.56M
March 31, 2019 10.79M
December 31, 2018 10.79M
September 30, 2018 13.01M
June 30, 2018 16.04M
March 31, 2018 18.36M
December 31, 2017 18.51M
September 30, 2017 17.20M
June 30, 2017 12.98M
March 31, 2017 10.25M
December 31, 2016 10.86M
September 30, 2016 11.04M
June 30, 2016 11.07M
March 31, 2016 9.449M
December 31, 2015 5.810M
September 30, 2015 2.000M
June 30, 2015 0.5055M
March 31, 2015 0.0275M
December 31, 2014 0.0328M
September 30, 2014 0.0365M
June 30, 2014 0.0379M
March 31, 2014 0.0301M
December 31, 2013 0.0272M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
LENZ Therapeutics, Inc. 151.57M
Impact BioMedical, Inc. 0.349M
ANI Pharmaceuticals, Inc. 324.76M
Corcept Therapeutics, Inc. 556.47M
Veru, Inc. 16.05M